Paul Hudson Joins Insmed Board, Reports Zero Initial Equity Holdings
INSMED Inc
Subscribe to track INSM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Initial Statement of Beneficial Ownership (Form 3) Company: INSMED Inc ($INSM) Reporting Person: Paul Hudson Role: Director Effective Date: 2026-10-19 Securities Held: 0 shares Significance: Low (Administrative initial filing with no reported equity holdings)
Comprehensive Analysis
Overview
On October 20, 2026, Paul Hudson filed an initial statement of beneficial ownership on Form 3 with the U.S. Securities and Exchange Commission, disclosing his status as a director of INSMED Inc ($INSM), effective as of October 19, 2026.
Key Takeaways
- Role: Director
- Beneficial Ownership: The filing explicitly indicates that no securities are beneficially owned (
<noSecuritiesOwned>1</noSecuritiesOwned>). - Exhibits: The filing includes Exhibit 24, granting limited power of attorney to designated agents (Michael A. Smith, Katrina S. Atieh, and Ian S. Macdonald) for SEC Section 16 reporting.
Market Impact & Significance
This is a standard administrative filing following the appointment of a new director to the board of Insmed Inc. Because no transactions were executed and no initial equity stakes were reported, the trading significance is evaluated as Low. Subsequent equity grants or open-market purchases will be disclosed via future Form 4 filings.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.